StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.16−0.11 (-2.58%)

Close on Nov 19, 2026Market cap $1.49BP/E –Yield –

Precigen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Precigen's shares outstanding was 414M at Jun 30, 2026. For fiscal 2025 it was 313M, up 16.9% from the year before. Over ten years it grew 10.9% a year on average. The highest annual figure on record is 313M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025313M+16.9%
FY2024Dec 31, 2024268M+9.5%
FY2023Dec 31, 2023245M+22.0%
FY2022Dec 31, 2022200M+1.3%
FY2021Dec 31, 2021198M+18.4%
FY2020Dec 31, 2020167M+8.4%
FY2019Dec 31, 2019154M+19.0%
FY2018Dec 31, 2018130M+7.9%
FY2017Dec 31, 2017120M+1.7%
FY2016Dec 31, 2016118M+6.2%
FY2015Dec 31, 2015111M+12.0%
FY2014Dec 31, 201499M+142.2%
FY2013Dec 31, 201341M+640.0%
FY2012Dec 31, 20126M+5.6%
FY2011Dec 31, 20115M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026414M+39.6%
Q1 FY2026Mar 31, 2026354M+20.6%
Q4 FY2025Dec 31, 2025354M+20.9%
Q3 FY2025Sep 30, 2025307M+11.3%
Q2 FY2025Jun 30, 2025296M+17.5%
Q1 FY2025Mar 31, 2025294M+17.9%
Q4 FY2024Dec 31, 2024293M+17.8%
Q3 FY2024Sep 30, 2024276M+11.0%
Q2 FY2024Jun 30, 2024252M+1.8%
Q1 FY2024Mar 31, 2024249M+8.5%
Q4 FY2023Dec 31, 2023249M+24.0%
Q3 FY2023Sep 30, 2023249M+23.8%
Q2 FY2023Jun 30, 2023248M+23.7%
Q1 FY2023Mar 31, 2023230M+15.1%
Q4 FY2022Dec 31, 2022201M+0.7%
Q3 FY2022Sep 30, 2022201M+0.7%
Q2 FY2022Jun 30, 2022200M+0.7%
Q1 FY2022Mar 31, 2022200M+3.2%
Q4 FY2021Dec 31, 2021199M+11.8%
Q3 FY2021Sep 30, 2021199M+20.3%
Q2 FY2021Jun 30, 2021199M+21.3%
Q1 FY2021Mar 31, 2021193M+20.7%
Q4 FY2020Dec 31, 2020178M+14.9%
Q3 FY2020Sep 30, 2020166M+7.1%
Q2 FY2020Jun 30, 2020164M+6.7%
Q1 FY2020Mar 31, 2020160M+4.8%
Q4 FY2019Dec 31, 2019155M+18.0%
Q3 FY2019Sep 30, 2019155M+19.4%
Q2 FY2019Jun 30, 2019154M+18.9%
Q1 FY2019Mar 31, 2019153M+19.8%
Q4 FY2018Dec 31, 2018132M+8.9%
Q3 FY2018Sep 30, 2018130M+7.5%
Q2 FY2018Jun 30, 2018129M+8.0%
Q1 FY2018Mar 31, 2018128M+7.3%
Q4 FY2017Dec 31, 2017121M+1.8%
Q3 FY2017Sep 30, 2017121M+1.8%
Q2 FY2017Jun 30, 2017120M–
Q1 FY2017Mar 31, 2017119M–
Q4 FY2016Dec 31, 2016119M–
Q3 FY2016Sep 30, 2016118M–

More Precigen figures

See a number that looks wrong?